<DOC>
	<DOCNO>NCT00365300</DOCNO>
	<brief_summary>To assess efficacy pantoprazole treatment infant symptomatic Gastroesophageal Reflux Disease ( GERD ) .</brief_summary>
	<brief_title>Study Evaluating Efficacy Safety Pantoprazole Infants With Symptomatic Gastroesophageal Reflux Disease ( GERD )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>term post term infant beyond neonatal period age great 28 day less equal 11 month clinical diagnosis GERD weight great 2.5 kg less equal 15 kg know history upper GI anatomic disorder history acute lifethreatening medical condition clinically significant medical condition laboratory abnormality</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>11 Months</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>GERD</keyword>
	<keyword>Infants</keyword>
	<keyword>Gastroesophageal Reflux</keyword>
</DOC>